Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney DiseaseYonghui Hu, Congqing Pan|Drug Design Development and Therapy|2022Cited by 38